Santos T., Ribeiro L., Lobo C., Bernardes R., Serranho P. Validation of the automatic identification of eyes with diabetic retinopathy by OCT. IEEE 2nd Portuguese Meeting in Bioengineering (ENBENG), 2012 [more info]
Lobo C., Pires I., Cunha-Vaz J. Diabetic Macular Edema. In: Optical Coherence Tomography: A Clinical and Technical Update. Rui Bernardes et al., Ed. Springer. 2012: Chapter 1. In press [more info]
Lobo C. Pseudophakic Cystoid Macular Edema. Ophthalmologica 2012;227(2):[Epub ahead of print] (DOI: 10.1159/000331277). [more info]
Franqueira N., Cachulo M.L., Pires I., Fonseca P., Marques I., Figueira J., Silva R. Long-Term Follow-Up of Myopic Choroidal Neovascularization Treated with Ranibizumab. Ophthalmologica 2012; 227(1):39-44 [more info]
Figueira J.P., Cunha-Vaz J. Severe macular ischemia in a poorly controlled diabetic patient. Diabetes Management 2012;2(1):21-23 [more info]
Fernandes R., Gonçalves A., Cunha-Vaz J. Blood-Retinal Barrier. The Fundamentals. In: Ocular Drug Delivery: Barriers and application of Nanoparticulate Systems. Deepak Tassu and Gerald Chader, Eds. Chapter 7. In press [more info]
Cunha-Vaz J., Bernardes R., Santos T., Oliveira C., Lobo C., Pires I., Ribeiro L. Computer-Aided Detection of Diabetic Retinopathy Progression. In: Digital Teleretinal Screening. K. Yogesan at al, Ed. Springer-Verlag Berlin Heidelberg. 2012:59-66 [more info]
Bandello F., Cunha-Vaz J., Chong N.V., Lang G.E., Massin P., Michell P., Porta M., Prunte C., Schlingenmann R., Schmidt-Erfurth U. New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel. Eye 2012; In Press [more info]
Sultan M., Zhou D., Loftus J. et al, for the Macugen 1013 Study Group. A Phase 2/3, Multicentre, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema. Ophthalmology 2011;118:1107-1118. [more info]
Schmidt-Erfurth U., Eldem B., Guymer R., Korobelnik J.F., Schlingemann R.O., Axer-Siegel R., Wiedemann P., Simader C., Gekkieva M., Weichselberger A.; EXCITE Study Group Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study. Ophthalmology. 2011;118(5):831-9. [more info]